ASCL1 and neuroblastoma: Higher levels of ASCL1 are associated with poorer neuroblastoma disease outcomes (Wang et al., 2019), and ASCL1 expression in neuroblastoma is negatively correlated with expression of genes involved in terminal neuronal differentiation (Kasim et al., 2016).